Rhode Island Hospital
Providence, Rhode Island, 02903, United States
NCT Number: NCT00237406
This study is designed to test whether a telephone call-in program is a feasible way to collect mood and drug-related information in individuals enrolled in a methadone maintenance program.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Providence, Rhode Island, 02903, United States
Participants will complete a baseline interview and a follow-up interview at 5-weeks post-baseline. Two-thirds of the participants will be randomized into the telephone call-in group, and will be asked to complete daily, 10-minute, telephone interviews. To complete these interviews, participants will call into a toll-free telephone interview system with a unique and private Study ID number, and answers questions by using the telephone key pad. Questions during both the face-to-face interviews and the telephone interviews will assess mood, sleep, treatment utilization and drug-related experiences. Participants will be compensated for their time.
Comparison(s): Participants randomized into the telephone component of the study as compared to participants in the interview-only component of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Butler Hospital
Other
Interactive Voice Response for Methadone Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02526212
Chemically-Induced Disorders, Mental Disorders
The Bronx, New York, United States
View Trial DetailsNCT04325659
Chemically-Induced Disorders, Mental Disorders
Baltimore, Maryland, United States
View Trial DetailsNCT05651516
Brain Diseases, Central Nervous System Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05380440
Amphetamine-Related Disorders, Chemically-Induced Disorders
Eugene, Oregon, United States
View Trial Details